Skip to main content
Caplight Logo









Paralos Bioscience

Paralos Bioscience

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://paralos.bio/

Last Round

Seed

Aug 27, 2026

Total Funding Raised

$566,484

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Paralos Bioscience is a biotechnology company developing a phage-drug conjugate platform for targeted therapeutic payload delivery to combat drug-resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

phage therapyphage-drug conjugatedrug delivery platformmultidrug-resistant bacteriaM13 bacteriophagetargeted therapyantibiotic alternativesGram-negative infectionsbiotech licensingdrug development platformprecision medicinebacterial infection treatmentsuperbug treatmentphage engineeringbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paralos Bioscience Comparables

Compare Paralos Bioscience with similar companies based on industry and business-model similarity.

Paralos Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PhalconBio GmbH
80%
Obulytix
77%
Locus Biosciences
76%

Paralos Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 27, 2026
AcceleratorMay 28, 2025

Paralos Bioscience Investors

Notable investors and investment history

Paralos Bioscience investors
InvestorRounds
INCATESeed, Accelerator
Carbon Silicon VenturesSeed
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2026

    Seed round raised with participation from Carbon Silicon Ventures, INCATE, and Larta Institute.

  • May 28, 2025

    $260K raised from INCATE

Paralos Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Paralos Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Paralos Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range3
Year Founded2024
Last FundingAug 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?